Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA Topoisomerase 2 (Top2) is a type II topoisomerase enzyme that manages DNA topology by introducing transient double-strand breaks, allowing DNA segment passage, and religating the strands. It is essential for replication, transcription, recombination, and chromosome segregation. Top2 is a target for anticancer drugs that stabilize the cleavage complex, causing cell death, but this can lead to safety concerns like secondary malignancies.
Topoisomerase poisons stabilize the Top2-DNA cleavage complex, leading to DNA double-strand breaks and cell death.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Topoisomerase 2 (Top2).